Blood Pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic overlap of chronic obstructive pulmonary disease and cardiovascular disease-related traits: a large-scale genome-wide cross-trait analysis.
|
30940143 |
2019 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Characterizing rare and low-frequency height-associated variants in the Japanese population.
|
31562340 |
2019 |
Red Blood Cell Count measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Chronic Obstructive Airway Disease
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic overlap of chronic obstructive pulmonary disease and cardiovascular disease-related traits: a large-scale genome-wide cross-trait analysis.
|
30940143 |
2019 |
Finding of Mean Corpuscular Hemoglobin
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Tonometry
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association analyses identify new loci influencing intraocular pressure.
|
29617998 |
2018 |
Systolic Pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation.
|
27841878 |
2017 |
Systolic Pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension.
|
27618447 |
2016 |
Hepatitis C
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
The kinase C-related kinase 2 (PRK2), which phosphorylates hepatitis C virus (HCV) RNA polymerase, is a proviral factor enhancing HCV replication.
|
30127498 |
2018 |
Hepatitis C
|
0.020 |
Biomarker
|
disease |
BEFREE |
Thus, as Ser76 is absolutely conserved across HCV genotypes, our results confirmed the relevance of these sites for both genotypes and suggested that Ser76 becomes phosphorylated by a cellular kinase different from PRK2.
|
26301630 |
2015 |
Heart failure
|
0.010 |
Biomarker
|
disease |
BEFREE |
To explore the role of PKNs in heart failure, we generated tamoxifen-inducible, cardiomyocyte-specific PKN1- and PKN2-knockout mice by intercrossing the αMHC-CreERT2 line with <i>Pkn1</i><sup>flox/flox</sup> and <i>Pkn2</i><sup>flox/flox</sup> mice and applied a mouse model of transverse aortic constriction- and angiotensin II-induced heart failure.
|
31564129 |
2019 |
Congestive heart failure
|
0.010 |
Biomarker
|
disease |
BEFREE |
To explore the role of PKNs in heart failure, we generated tamoxifen-inducible, cardiomyocyte-specific PKN1- and PKN2-knockout mice by intercrossing the αMHC-CreERT2 line with <i>Pkn1</i><sup>flox/flox</sup> and <i>Pkn2</i><sup>flox/flox</sup> mice and applied a mouse model of transverse aortic constriction- and angiotensin II-induced heart failure.
|
31564129 |
2019 |
Malignant tumor of colon
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
PKN2 expression in human colon cancer tissues was examined with immunohistochemistry (IHC).
|
29368606 |
2018 |
Neoplasm Metastasis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
PKN2 is required for tumor cell migration, invasion and apoptosis.
|
29368606 |
2018 |
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
The effects of PKN2 on tumor growth and TAM polarization were investigated both in vitro and in vivo.
|
29368606 |
2018 |
Malignant Head and Neck Neoplasm
|
0.010 |
Biomarker
|
disease |
BEFREE |
Silencing of PKN2 resulted in decreased colony formation, invasion and migration in both smoke exposed cells and head and neck cancer cell lines.
|
29480433 |
2018 |
Colon Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
PKN2 expression in human colon cancer tissues was examined with immunohistochemistry (IHC).
|
29368606 |
2018 |
Squamous cell carcinoma of the head and neck
|
0.010 |
Biomarker
|
disease |
BEFREE |
The current study provides evidence that PKN2 can act as a potential therapeutic target in head and neck squamous cell carcinoma, especially in patients with a history of smoking.
|
29480433 |
2018 |
Head and Neck Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Silencing of PKN2 resulted in decreased colony formation, invasion and migration in both smoke exposed cells and head and neck cancer cell lines.
|
29480433 |
2018 |
Squamous cell carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Triple knockout of Pten, Pkn1, and Pkn2 in mouse prostate results in squamous cell carcinoma, an uncommon but therapy-resistant form of prostate cancer.
|
28875501 |
2017 |
Encephalomyelitis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Expression levels of cortical miR-6315, miR-3588, and miR-466b-5p were upregulated, and positively correlated with the genes Pkn2 (astrocyte migration), Gorab (neuritogenesis), and Mobp (allergic encephalomyelitis).
|
27539004 |
2017 |
Malignant neoplasm of prostate
|
0.010 |
Biomarker
|
disease |
BEFREE |
Triple knockout of Pten, Pkn1, and Pkn2 in mouse prostate results in squamous cell carcinoma, an uncommon but therapy-resistant form of prostate cancer.
|
28875501 |
2017 |
Prostate carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Triple knockout of Pten, Pkn1, and Pkn2 in mouse prostate results in squamous cell carcinoma, an uncommon but therapy-resistant form of prostate cancer.
|
28875501 |
2017 |
Triple Negative Breast Neoplasms
|
0.010 |
Biomarker
|
disease |
BEFREE |
This indicates that PKN2 is required for the survival of TNBC cells, and could be the target mediates the selective activity of chelerythrine.
|
28515445 |
2017 |
Triple-Negative Breast Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
This indicates that PKN2 is required for the survival of TNBC cells, and could be the target mediates the selective activity of chelerythrine.
|
28515445 |
2017 |